BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23503045)

  • 1. Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications.
    Gilbert RE
    Circ J; 2013; 77(4):849-56. PubMed ID: 23503045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.
    Dong Y; Fernandes C; Liu Y; Wu Y; Wu H; Brophy ML; Deng L; Song K; Wen A; Wong S; Yan D; Towner R; Chen H
    Diab Vasc Dis Res; 2017 Jan; 14(1):14-23. PubMed ID: 27941052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications.
    Yang DR; Wang MY; Zhang CL; Wang Y
    Front Endocrinol (Lausanne); 2024; 15():1359255. PubMed ID: 38645427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking diabetic vascular complications with LncRNAs.
    Leung A; Amaram V; Natarajan R
    Vascul Pharmacol; 2019 Mar; 114():139-144. PubMed ID: 29398367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.
    Spinetti G; Kraenkel N; Emanueli C; Madeddu P
    Cardiovasc Res; 2008 May; 78(2):265-73. PubMed ID: 18281374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
    Gimbrone MA; García-Cardeña G
    Circ Res; 2016 Feb; 118(4):620-36. PubMed ID: 26892962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.
    Keats EC; Khan ZA
    Cardiovasc Diabetol; 2012 Apr; 11():37. PubMed ID: 22524626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular mechanisms of endothelial dysfunction in diabetes.
    Roberts AC; Porter KE
    Diab Vasc Dis Res; 2013 Nov; 10(6):472-82. PubMed ID: 24002671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical techniques to investigate exercise training in vascular pathophysiology.
    Sangha GS; Goergen CJ; Prior SJ; Ranadive SM; Clyne AM
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1566-H1600. PubMed ID: 33385323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.
    Wang Y; Chen LM; Liu ML
    Acta Pharmacol Sin; 2014 Apr; 35(4):433-43. PubMed ID: 24608676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.
    Puri R; Kataoka Y; Uno K; Nicholls SJ
    Curr Diab Rep; 2012 Jun; 12(3):280-5. PubMed ID: 22492060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE and its ligands: a lasting memory in diabetic complications?
    Yan SF; Ramasamy R; Bucciarelli LG; Wendt T; Lee LK; Hudson BI; Stern DM; Lalla E; DU Yan S; Rong LL; Naka Y; Schmidt AM
    Diab Vasc Dis Res; 2004 May; 1(1):10-20. PubMed ID: 16305050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current views on neuropeptide Y and diabetes-related atherosclerosis.
    Sun WW; Zhu P; Shi YC; Zhang CL; Huang XF; Liang SY; Song ZY; Lin S
    Diab Vasc Dis Res; 2017 Jul; 14(4):277-284. PubMed ID: 28423914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus.
    Carracedo J; Alique M; Ramírez-Carracedo R; Bodega G; Ramírez R
    Curr Vasc Pharmacol; 2019; 17(5):447-454. PubMed ID: 30124156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-mesenchymal transition in atherosclerosis.
    Souilhol C; Harmsen MC; Evans PC; Krenning G
    Cardiovasc Res; 2018 Mar; 114(4):565-577. PubMed ID: 29309526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arteriolosclerosis and atherosclerosis. Pathology of the distal and proximal arterial bed. Pathogenesis of diabetic microangiopathy].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Apr; (4):3-14. PubMed ID: 21739639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial endothelial cells: still the craftsmen of regenerated endothelium.
    Hagensen MK; Vanhoutte PM; Bentzon JF
    Cardiovasc Res; 2012 Aug; 95(3):281-9. PubMed ID: 22652005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Development-A New Paradigm for Understanding Vascular Disease.
    Flavahan NA
    J Cardiovasc Pharmacol; 2017 May; 69(5):248-263. PubMed ID: 28328747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.